Figure 2
SEA induces expression of IL-10 from primary malignant T cells. (A) PBMCs were isolated from 7 SS patients and cultured with vehicle (PBS) or SEA (200 ng/mL). After 24 hours, the concentrations of IL-10 in the cell culture supernatants were determined by ELISA. Error bars represent SEM. (B) Flow cytometric analysis of IL-10 expressing malignant (CD4+CD26−) T cells, benign (CD4+CD26+) T cells, and CD4-negative cells (CD4−) in SS PBMCs cultured with vehicle (PBS) or SEA (200 ng/mL) for 24 hours. (C) Representative flow cytometric analysis of MHC-II expression on malignant (CD4+CD26−) and benign (CD4+CD26+) T cells in PBMCs isolated from the blood of an SS patient. Dashed lines represent isotype control staining and solid lines with fill MHC-II staining. Flow cytometric analysis of MHC-II expression on malignant and benign T cells from 5 SS patients are summarized in supplemental Figure 7.

SEA induces expression of IL-10 from primary malignant T cells. (A) PBMCs were isolated from 7 SS patients and cultured with vehicle (PBS) or SEA (200 ng/mL). After 24 hours, the concentrations of IL-10 in the cell culture supernatants were determined by ELISA. Error bars represent SEM. (B) Flow cytometric analysis of IL-10 expressing malignant (CD4+CD26) T cells, benign (CD4+CD26+) T cells, and CD4-negative cells (CD4) in SS PBMCs cultured with vehicle (PBS) or SEA (200 ng/mL) for 24 hours. (C) Representative flow cytometric analysis of MHC-II expression on malignant (CD4+CD26) and benign (CD4+CD26+) T cells in PBMCs isolated from the blood of an SS patient. Dashed lines represent isotype control staining and solid lines with fill MHC-II staining. Flow cytometric analysis of MHC-II expression on malignant and benign T cells from 5 SS patients are summarized in supplemental Figure 7.

Close Modal

or Create an Account

Close Modal
Close Modal